Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,812,468
in 11 filings, $79.8M under 10b5-1 plans

Net −$79,812,468. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-01-03 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −2,066 $19.10 $39K 59,883
2024-12-26 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise 10b5-1 +15,000 $12.67 $190K 69,927
2024-12-26 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale 10b5-1 −15,000 $17.22 $258K 54,927
2024-12-26 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise · Employee stock option (right to buy) 10b5-1 −15,000 0
2024-11-25 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise +15,000 $12.67 $190K 67,017
2024-11-25 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale −12,090 $18.30 $221K 54,927
2024-11-25 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise · Employee stock option (right to buy) −15,000 15,000
2024-10-04 LYONS GARY A Director Option exercise 10b5-1 +40,000 $10.48 $419K 91,000
2024-10-04 LYONS GARY A Director Sale 10b5-1 −21,179 $14.35 $304K 69,821
2024-10-04 LYONS GARY A Director Sale 10b5-1 −18,821 $15.15 $285K 51,000
2024-10-04 LYONS GARY A Director Option exercise · Stock option (right to buy) 10b5-1 +40,000 0
2024-09-30 Meckler Jeffrey A Director Option exercise 10b5-1 +40,000 $10.48 $419K 121,000
2024-09-30 Meckler Jeffrey A Director Sale 10b5-1 −40,000 $14.06 $562K 81,000
2024-09-30 Meckler Jeffrey A Director Option exercise · Stock option (right to buy) 10b5-1 +40,000 0
2024-09-10 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −684 $12.98 $9K 61,949
2024-09-09 ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D Sale 10b5-1 −4,387 $11.52 $51K 84,455
2024-09-09 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Sale 10b5-1 −4,387 $11.52 $51K 78,633
2024-09-09 Dube Eric M CHIEF EXECUTIVE OFFICER Sale 10b5-1 −21,125 $11.52 $243K 361,975
2024-09-09 Inrig Jula CHIEF MEDICAL OFFICER Sale −2,191 $11.52 $25K 62,633
2024-09-09 Heerma Peter CHIEF COMMERCIAL OFFICER Sale −2,191 $11.52 $25K 107,958

Page 22 of 51 · 1,020 trades